What is it about?
When breast cancer cells break away from healthy tissue, they normally die. Some instead survive and spread to other organs. We asked why. We studied a protein called NRF1, known for controlling mitochondria, the cell's power plants. In lab-grown breast cancer cells, we raised NRF1 levels and tracked what changed. NRF1 boosted energy production, which also created harmful byproducts called reactive oxygen species. At the same time, NRF1 switched on cleanup enzymes that kept those byproducts low. This balance helped detached cells avoid death and gain invasive traits. Our findings link NRF1 to breast cancer spread.
Featured Image
Photo by Sasun Bughdaryan on Unsplash
Why is it important?
Most cancer deaths come from cells that detach, survive, and colonize new organs. Our study shows how a single protein, NRF1, drives that process in breast cancer. NRF1 increased mitochondrial energy output (oxidative phosphorylation and ATP) while simultaneously raising ROS-scavenging enzymes, keeping reactive oxygen species low. Detached cells normally die from ROS buildup; NRF1 lets them escape that fate and undergo EMT, the cell-state change linked to invasion and metastasis. This identifies a concrete, druggable weakness: blocking NRF1 might make detached cancer cells vulnerable again. It also gives other researchers a framework for studying energy metabolism and stress balance in metastasis. Next, we need to test whether NRF1 targeting works in patients.
Perspectives
I still remember seeing detached cells thriving in the dish when they should have been dying that moment convinced me the ROS balance was the key. This work took years of patient collaboration with colleagues who each saw a different piece of the puzzle. My hope is that readers walk away thinking about cancer cells not just as growing machines, but as cells managing an energy-and-waste tradeoff. If that idea sticks, I'll be happy.
Dr Shaheryar Shafi
University of Science and Technology of China
Read the Original
This page is a summary of: NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis, Technology in Cancer Research & Treatment, January 2023, SAGE Publications,
DOI: 10.1177/15330338231161141.
You can read the full text:
Contributors
The following have contributed to this page
